White Guide and Orange Guide Formatting Project - Pfizer

“Not-for-Profit” Defined
Orange Guide – Chapter 3: Support of External Organizations
A “not-for-profit” (also referred to as a “non-profit”) organization is an organization that does not
distribute its profits to its owners and is typically organized for educational, charitable, or scientific
purposes. The Funding SOP applies to entities that have been designated as not-for-profit by
appropriate state and federal agencies, including but not limited to: 1) certain charities and patient
advocacy groups designated by a 501(c)(3) status; 2) professional medical associations or chambers of
commerce (501(c)(6) status; and 3) cultural and civic organizations (501(c)(4) status).
Sponsorships
Sponsorships are funding opportunities provided by either for-profit or not-for-profit organizations that
present a “tangible benefit” to Pfizer. They can be funded by all Pfizer groups in accordance with the
processes and requirements described in this Chapter. A tangible benefit is any legitimate,
appropriate and business-oriented benefit to the proprietary interests, business, or public policy goals
of Pfizer or its products, services or programs. The receipt of general recognition or incidental goods or
services that do not directly promote Pfizer business goals in and of itself does not constitute a tangible
benefit. A tangible benefit must provide the opportunity to truly advertise or advance Pfizer business
interests, e.g., to educate customers and/or prescribers about the specific attributes of our products
and/or services.
Any funding request that does not include a tangible benefit in return for funding will not be
treated as a sponsorship but rather as a charitable contribution. As discussed in the next section,
Sales Colleagues are not permitted to make any charitable contributions. All other colleagues
(including CGC) are not permitted to make healthcare charitable contributions but are permitted to
make appropriate non-healthcare charitable contributions. Colleagues may not ask a requesting
organization to change the associated benefits being offered for funding in order to impact the
classification or source of funding within Pfizer.
57
Rev. 09/12
Page 13 of 26